NCT00882778View on ClinicalTrials.gov

PROPACT: Retrospective Prophylaxis Patient Case Collection

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Interventions
DRUG

eptacog alfa (activated)

Retrospective data collection of the use of activated recombinant human factor VII as prophylaxis in haemophilia patients with inhibitors

Trial Locations (14)

16000

Novo Nordisk Investigational Site, Prague

28033

Novo Nordisk Investigational Site, Madrid

55127

Novo Nordisk Investigational Site, Mainz

92932

Novo Nordisk Investigational Site, Paris La Défense Cedex

08540

Novo Nordisk Investigational Site, Princeton

B1636DSU

Novo Nordisk Investigational Site, Prov. de Buenos Aires

L4W 4XI

Novo Nordisk Investigational Site, Mississauga

10 000

Novo Nordisk Investigational Site, Zagreb

Unknown

Novo Nordisk Investigational Site, Dublin

00144

Novo Nordisk Investigational Site, Rome

811 05

Novo Nordisk Investigational Site, Bratislava

202 15

Novo Nordisk Investigational Site, Malmo

CH-8050

Novo Nordisk Investigational Site, Zurich

RH11 9RT

Novo Nordisk Investigational Site, Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY